NPI: 1942567839 · HOLLYWOOD, FL 33020 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/16/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/16/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,231 | $3.98M |
| 2019 | 19,343 | $4.98M |
| 2020 | 24,483 | $4.27M |
| 2021 | 18,514 | $1.50M |
| 2022 | 11,048 | $1.04M |
| 2023 | 3,021 | $341K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 30,935 | 1,183 | $5.10M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,086 | 1,597 | $4.80M |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,129 | 960 | $3.06M |
| J1756 | Injection, iron sucrose, 1 mg | 5,679 | 889 | $843K |
| A4657 | Syringe, with or without needle, each | 2,777 | 1,422 | $654K |
| 85041 | 1,862 | 1,232 | $315K | |
| 85048 | 1,863 | 1,232 | $315K | |
| 83550 | 1,226 | 797 | $238K | |
| 83540 | 1,230 | 797 | $237K | |
| 83970 | 991 | 700 | $202K | |
| 82728 | 828 | 548 | $152K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 517 | 347 | $91K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 261 | 134 | $54K |
| 82108 | 131 | 97 | $21K | |
| 82746 | 70 | 58 | $16K | |
| 85046 | 26 | 25 | $7K | |
| 82607 | 12 | 12 | $5K | |
| G0008 | Administration of influenza virus vaccine | 17 | 12 | $3K |